Breaking News Instant updates and real-time market news.

PTHN

Bought by TMO

, RHHBY

Roche

$28.02

0.6 (2.19%)

09:16
11/28/16
11/28
09:16
11/28/16
09:16

Patheon to acquire manufacturing site in Florence, South Caroline from Roche

Patheon N.V. (PTHN) announced that it has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc., an indirect, wholly owned subsidiary of Roche Holding Ltd (RHHBY), which it will integrate into the Patheon network. Under the terms of the purchase agreement, Patheon will acquire the site for an immaterial sum, plus the cost of associated inventory and spare parts. Patheon has also entered into a multi-year supply arrangement with Roche. Patheon expects the supply agreement to help defray the costs associated with running the site for the next few years while it adds new client work into the facility. Over time, Patheon expects the Florence facility to have a similar financial profile to its other sites in its drug substance segment. Patheon will acquire a 1,100 acre, 300,000 square-foot facility with manufacturing capacity for API ranging from development to manufacturing services. With the addition of this site, the company expands its capacity for manufacturing highly potent compounds, and adds capabilities to support solid-state chemistry, micronization, and eventually, commercial spray drying.

PTHN

Bought by TMO

RHHBY

Roche

$28.02

0.6 (2.19%)

  • 29

    Nov

  • 03

    Dec

PTHN Bought by TMO

08/15/16
08/15/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Symantec (SYMC) reinstated with a Buy at Goldman. 2. Diebold (DBD) resumed with a Neutral at JPMorgan. 3. LifeLock (LOCK) initiated with a Neutral at Goldman. 4. Patheon (PTHN) initiated with an Overweight at Piper Jaffray, an Outperform at Baird, an Overweight at JPMorgan, an Overweight at KeyBanc, a Buy at UBS, an Outperform at Wells Fargo, an Outperform at Raymond James, an Overweight at Morgan Stanley, and an Outperform at William Blair. 5. Impinj (PI) initiated with an Overweight at Piper Jaffray, an Outperform at RBC Capital, an Overweight at Pacific Crest, a Buy at Canaccord, and a Buy at Needham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/15/16
EVER
08/15/16
INITIATION
Target $33
EVER
Buy
Patheon initiated with a Buy at Evercore ISI
Evercore ISI analyst Ross Muken initiated Patheon with a Buy and $33 price target.
08/15/16
JEFF
08/15/16
INITIATION
Target $32
JEFF
Buy
Patheon initiated with a Buy at Jefferies
Jefferies analyst David Windley initiated Patheon with a Buy and $32 price target.
11/10/16
LEER
11/10/16
INITIATION
Target $31
LEER
Outperform
Patheon initiated with an Outperform at Leerink
Leerink analyst Puneet Souda started Patheon with an Outperform rating and $31 price target.
RHHBY Roche
$28.02

0.6 (2.19%)

09/12/16
JEFF
09/12/16
NO CHANGE
Target $57
JEFF
Hold
Jefferies cuts Bristol-Myers price target, upgrades AstraZeneca
Jefferies analyst Jeffrey Holford lowered his price target for Bristol-Myers Squibb (BMY) to $57 from $69 saying the stock is positioned for a "rough mid term ride." The analyst sees a "difficult catalyst" set for Bristol shares with "numerous" upcoming competitor read-outs in non-small cell lung cancer. The market could see worse than expected data from Bristol's CM-026 and CM-568 studies as well as better than expected data from AstraZeneca's (AZN) MYSTIC study and Roche's (RHHBY) Chemo-IO studies in the first half of 2017, Holford tells investors in a research note. He keeps a Hold rating on Bristol and upgraded this morning AstraZeneca to Buy from Hold. Holford prefers Astra for its immunology exposure.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.
10/19/16
LEER
10/19/16
NO CHANGE
LEER
Roche Tecentriq approval increases competition, says Leerink
Leerink analyst Seamus Fernandez says that the FDA approval of Roche's (RHHBY) Tecentriq in second-line non-small cell lung cancer patients regardless of PD-L1 expression comes as no surprise given its previously reported overall survival advantage. Nonetheless, the analyst believes it creates new competition for Bristol-Myers' (BMY) Opdivo and Merck's (MRK) Keytruda in this setting.
11/09/16
SBSH
11/09/16
NO CHANGE
SBSH
Citi sees Healthcare 'relief rally' after Trump win
Citi analyst Andrew Baum expects a "'relief rally" to drive near-term sector outperformance for names in the Healthcare space given the "inability of the Democrats to attain the Presidency, the House or Congress." Longer term, however, the analyst still sees "significant continued legislative risk" for pharma reimbursement. Baum prefers GlaxoSmithKline (GSK), AstraZeneca (AZN), Shire (SHPG) and Roche (RHHBY) among European majors and Bristol-Myers (BMY) and Eli Lilly (LLY) in the U.S.

TODAY'S FREE FLY STORIES

DVA

DaVita

$60.84

-0.42 (-0.69%)

11:26
09/22/17
09/22
11:26
09/22/17
11:26
Hot Stocks
DaVita slides after SIRF questions 'massive' leverage to non-profit »

Share of DaVita (DVA) are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$9.29

0.21 (2.31%)

11:25
09/22/17
09/22
11:25
09/22/17
11:25
Options
Transocean call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

11:25
09/22/17
09/22
11:25
09/22/17
11:25
General news
Treasury Action: supply hits next week with $88 B in shorter dated coupons »

Treasury Action: supply…

MSFT

Microsoft

$74.21

-0.73 (-0.97%)

11:25
09/22/17
09/22
11:25
09/22/17
11:25
Conference/Events
Piper Jaffray technology analysts hold an analyst/industry conference call »

Technology Research Team…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 02

    Oct

  • 22

    Oct

DVA

DaVita

$60.94

-0.32 (-0.52%)

11:23
09/22/17
09/22
11:23
09/22/17
11:23
Periodicals
DaVita mentioned cautiously by Southern Investigative Reporting Foundation 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
09/22/17
09/22
11:17
09/22/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$103.15

4.9 (4.99%)

11:16
09/22/17
09/22
11:16
09/22/17
11:16
Hot Stocks
Wells Fargo says time to buy Equifax shares »

Wells Fargo upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

$NYE

NYSE Market Internals

11:16
09/22/17
09/22
11:16
09/22/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$124.96

0.17 (0.14%)

11:15
09/22/17
09/22
11:15
09/22/17
11:15
Options
Caterpillar put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CSIQ

Canadian Solar

$15.86

-0.16 (-1.00%)

, JKS

JinkoSolar

$25.83

-0.18 (-0.69%)

11:13
09/22/17
09/22
11:13
09/22/17
11:13
Hot Stocks
Chinese solar names move lower after ITC vote on injury to U.S. producers »

Shares of Canadian Solar…

CSIQ

Canadian Solar

$15.86

-0.16 (-1.00%)

JKS

JinkoSolar

$25.83

-0.18 (-0.69%)

JASO

JA Solar

$7.85

-0.335 (-4.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLR

First Solar

$48.76

-0.09 (-0.18%)

11:12
09/22/17
09/22
11:12
09/22/17
11:12
Hot Stocks
Breaking Hot Stocks news story on First Solar »

First Solar trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLR

First Solar

$48.76

-0.09 (-0.18%)

, SPWR

SunPower

$7.37

-0.49 (-6.23%)

11:11
09/22/17
09/22
11:11
09/22/17
11:11
Hot Stocks
First Solar jumps 6%, halted after ITC finds injury to U.S. solar product makers »

SunPower (SPWR) is down…

FSLR

First Solar

$48.76

-0.09 (-0.18%)

SPWR

SunPower

$7.37

-0.49 (-6.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$366.48

-7.43 (-1.99%)

11:09
09/22/17
09/22
11:09
09/22/17
11:09
Hot Stocks
Solar City agrees to pay $29.5M to resolve alleged False Claims Act violations »

The Justice Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FSLR

First Solar

$48.76

-0.09 (-0.18%)

11:08
09/22/17
09/22
11:08
09/22/17
11:08
Hot Stocks
Breaking Hot Stocks news story on First Solar »

First Solar jumps after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLR

First Solar

11:07
09/22/17
09/22
11:07
09/22/17
11:07
Hot Stocks
Breaking Hot Stocks news story on First Solar »

First Solar trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$49.20

0.71 (1.46%)

11:05
09/22/17
09/22
11:05
09/22/17
11:05
Options
Anadarko call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

AVGO

Broadcom

$240.38

-2.53 (-1.04%)

, SWKS

Skyworks

$102.13

-1.38 (-1.33%)

11:03
09/22/17
09/22
11:03
09/22/17
11:03
Recommendations
Broadcom, Skyworks, Apple analyst commentary  »

Broadcom, Skyworks still…

AVGO

Broadcom

$240.38

-2.53 (-1.04%)

SWKS

Skyworks

$102.13

-1.38 (-1.33%)

AAPL

Apple

$153.39

-2.68 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

  • 22

    Oct

MHK

Mohawk

$245.50

-8.61 (-3.39%)

11:03
09/22/17
09/22
11:03
09/22/17
11:03
Technical Analysis
Technical View: Mohawk slides, analyst action »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYLD

NRG Yield

$19.20

0.05 (0.26%)

, NRG

NRG Energy

$24.01

-0.18 (-0.74%)

11:02
09/22/17
09/22
11:02
09/22/17
11:02
Hot Stocks
NRG Yield rises after said to be exploring strategic alternatives »

Shares of NRG Yield…

NYLD

NRG Yield

$19.20

0.05 (0.26%)

NRG

NRG Energy

$24.01

-0.18 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

11:00
09/22/17
09/22
11:00
09/22/17
11:00
General news
Treasury Option Action: some call buying at short-end »

Treasury Option Action:…

NYLD

NRG Yield

$19.20

0.05 (0.26%)

10:57
09/22/17
09/22
10:57
09/22/17
10:57
Periodicals
NRG Yield hires banks to explore strategic alternatives, SparkSpread says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLR

First Solar

$48.76

-0.09 (-0.18%)

10:55
09/22/17
09/22
10:55
09/22/17
10:55
Options
First Solar put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:50
09/22/17
09/22
10:50
09/22/17
10:50
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

AAL

American Airlines

$46.29

0.87 (1.92%)

, DAL

Delta Air Lines

$48.51

0.35 (0.73%)

10:47
09/22/17
09/22
10:47
09/22/17
10:47
Hot Stocks
Barclays, UBS positive on airlines following recent slide »

Two research firms issued…

AAL

American Airlines

$46.29

0.87 (1.92%)

DAL

Delta Air Lines

$48.51

0.35 (0.73%)

UAL

United Continental

$58.80

0.27 (0.46%)

JBLU

JetBlue

$18.90

-0.35 (-1.82%)

LUV

Southwest

$54.60

-0.03 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

IP

International Paper

$55.75

-1.54 (-2.69%)

, PKG

Packaging Corp.

$116.00

-2.8 (-2.36%)

10:40
09/22/17
09/22
10:40
09/22/17
10:40
Recommendations
International Paper, Packaging Corp., KapStone, WestRock analyst commentary  »

IP marks third capacity…

IP

International Paper

$55.75

-1.54 (-2.69%)

PKG

Packaging Corp.

$116.00

-2.8 (-2.36%)

KS

KapStone

$21.65

-0.93 (-4.12%)

WRK

WestRock

$55.80

-1.81 (-3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.